Stock screenerAll disclosures →
EDGAR →
SRZN
Conviction 47HealthcareScan · Thu, Jun 25, 2026SRZN$24.42-1.35%
ResistanceSupportVol 14Insider sell3
Vol MA14 158.8K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price24.42
Change-1.35%
Gap+1.86%
Rel volume4.97×
Avg volume149.98K
Avg $ vol3.59M
SMA 2023.61
SMA 5027.47
SMA 20021.57
Price vs 50-11.13%
Price vs 200+13.20%
MA stackmixed
50/200 cross—
Supertrenddown · 27.53
RSI (14)48
MACD hist0.43
MACD crossbull · 6d
Stoch %K / %D74 / 79
ADX (14)22
+DI / −DI21 / 16
RSI divergenceBearish
MACD divergenceBearish
ATR %+8.51%
ADR %8.81%
52w high34.13
52w low8.29
From 52w high-28.46%
Above 52w low+194.51%
New 52w highNo
SqueezeOff
Bollinger width24.50%
%B0.64
Donchian pos59.50%
Donchian high27.08
Donchian low20.50
AVWAP (52w high)25.87
vs AVWAP high-5.63%
AVWAP (52w low)22.46
vs AVWAP low+8.70%
OBV trendDown
Chaikin MF (20)-0.07
Today vs 20d4.97×
Avg vol (14d)158.8K
Avg vol (20d)149.98K
Avg $ vol (20d)3.59M
Market cap283.47M
RS 3m (vs SPY)-13.26%
RS 6m (vs SPY)+6.00%
RS line new highNo
Trend template4/8
Technical rank53.4
1 week+1.56%
1 month-6.71%
3 months-6.60%
6 months+6.15%
1 year+174.63%
YTD+13.29%
P/E-1.17
P/B-1.02
P/S81.53
P/FCF-9.33
EPS-32.37
Div yield—
ROE87.01%
ROA-200.50%
Debt/Eq—
Current11.91
EV/EBITDA-4.25
Gross margin—
Net margin—
Rev growth-67.37%
EPS growth-280.76%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value176.56M
Revenue5M
Net income-127.5M
Gross profit—
Free cash flow-30.37M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out11.61M
Employees44
ListedThu, Aug 12, 2021
Free float4.11M
Float %47.9%
Short interest551.84K
Days to cover5.4d
Short volume75.0%
Squeeze score87 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeC
Conviction47 / 100
Pattern quality—
Tech rank53.4 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance35.00
Support21.25
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in SRZN
No recent disclosed trades by Congress in SRZN. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in SRZN · 7 buys · 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Kutzkey Tim Director · Option (right to buy) · 2026-05-13 | Grant | 5.55K | $0 | 2026-05-13 | 2026-05-19 |
Haak-Frendscho Mary Director · Director Stock Option (right to buy) · 2026-05-13 | Grant | 5.55K | $0 | 2026-05-13 | 2026-05-14 |
Rothenberg Mace Director · Director Stock Option (right to buy) · 2026-05-13 | Grant | 5.55K | $0 | 2026-05-13 | 2026-05-14 |
Berkenblit Anna Director · Director Stock Option (right to buy) · 2026-05-13 | Grant | 5.55K | $0 | 2026-05-13 | 2026-05-14 |
CHAI CHRISTOPHER Y Director · Director Stock Option (right to buy) · 2026-05-13 | Grant | 5.55K | $0 | 2026-05-13 | 2026-05-14 |
WOODHOUSE DAVID J Director · Director Stock Option (right to buy) · 2026-05-13 | Grant | 5.55K | $0 | 2026-05-13 | 2026-05-14 |
BJERKHOLT ERIC Director · Director Stock Option (right to buy) · 2026-05-13 | Grant | 5.55K | $0 | 2026-05-13 | 2026-05-14 |
Williams Charles O Chief Operating Officer · Common Stock · 2026-05-04 | Sell | 2.04K | $68K | 2026-05-04 | 2026-05-05 |
Parker Craig C Chief Executive Officer · Common Stock · 2026-05-04 | Sell | 4.52K | $151K | 2026-05-04 | 2026-05-05 |
Li Yang Exec. Vice President, Research · Common Stock · 2026-05-04 | Sell | 1.58K | $53K | 2026-05-04 | 2026-05-05 |
SEC filings
EDGAR filings in SRZN
No recent SEC filings on file for SRZN.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.